Our research profile

Main research areas

In research, the focus of the Clinical Psychology and Sexual Medicine department is primarily on the areas of sexuality and couple relationships. In a tradition that now spans more than three decades, contributions have been made to each of the three major groups of sexual disorders: sexual dysfunctions, paraphilias and gender identity disorders. The focus has been on basic research (psychological and neurobiological) as well as on a broad spectrum of clinical issues. The current focus in the field of sexuality and couple relationships is on

  • Psycho-neuro-immunological and -endocrinological basic research on the psychobiology of healthy and disturbed sexual response

  • Clinical research into new drug and psychotherapeutic treatment concepts for male and female sexual dysfunction as well as paraphilias/sexual delinquency and gender identity disorders

  • Research into the connections between variables in couple relationships and couple sexuality, including the development of innovative therapy concepts

  • Research into the dysregulation of sexual impulse control (so-called 'sex addiction'), particularly in the area of internet use

Other key areas of research in our department - in line with the central clinical fields of activity - are psychotherapy research (process and outcome research, especially on inpatient psychotherapy) and behavioral therapy and behavioral medicine research.

Clinical studies

Research in the field of healthy sexuality and sexual disorders is already a tradition in our department. Since 1995, our department has been regularly involved in conducting clinical studies or carrying out its own studies on the subject.

For a long time, the focus was on erectile dysfunction and ejaculatio praecox in men and on pleasure and orgasm disorders and sexual satisfaction in women. From 1995, research into erectile dysfunction focused on the drugs sildenafil, vardenafil and tadalafil. Research on ejaculatio praecox was conducted in 2004-2006 and 2009-2010. Sildenafil, bupropion and Uprima were used in women with sexual desire or arousal disorders. In the years 2007-2009, research was carried out into the possible treatment of lust disorders with flibanserin.

With the opening of the Hanover site of the 'Kein Täter werden' prevention network and the 'I Can Change' prevention project, our research focus expanded to include basic research into paraphilias. In addition to this subject area, we are currently conducting studies on different styles of sexual activity in relationships and internet and sex addiction.